Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products

類似資料

• Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products
  著者:: Alessandro Aiuti, 等
  出版事項: (2017-04-01)
• Busulfan Pharmacokinetics in ADA SCID Gene Therapy
  著者:: Bradford, Kathryn L., 等
  出版事項: (2020)
• Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy
  著者:: Aiuti, Alessandro, 等
  出版事項: (2007)
• Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients
  著者:: Cassani, Barbara, 等
  出版事項: (2008)
• Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy
  著者:: Goudy, Kevin Scott, 等
  出版事項: (2011)